{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_13700", "batch_size": 217, "batch_pos": 91, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment describes a vaccine deal using neutral language.", "method": "llm_batch", "batch_id": "batch_2_10324", "batch_size": 197, "batch_pos": 72, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "Factual statement with numbers, 'secures' is not moderate verb + scale/impact of threat.", "method": "llm_batch", "batch_id": "batch_3_6400", "batch_size": 260, "batch_pos": 257, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment is a factual statement, not a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_10604", "batch_size": 260, "batch_pos": 247, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports facts about a deal but does not frame it as an explicit safety assurance.", "method": "llm_batch", "batch_id": "batch_5_17556", "batch_size": 260, "batch_pos": 244, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_16980", "batch_size": 260, "batch_pos": 204, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment describes deal details, not a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17176", "batch_size": 260, "batch_pos": 192, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes a deal securing doses ('deal secures up to 665,000 doses') without linking to current calm or safety.", "method": "llm_batch", "batch_id": "batch_8_15404", "batch_size": 260, "batch_pos": 255, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
